Log in
Enquire now
‌

US Patent 11407789 Cell-penetrating compstatin analogs and uses thereof

Patent 11407789 was granted and assigned to Apellis Pharmaceuticals on August, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Apellis Pharmaceuticals
Apellis Pharmaceuticals
0
Current Assignee
Apellis Pharmaceuticals
Apellis Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
114077890
Patent Inventor Names
Pascal Deschatelets0
Monica Gerber0
Cedric Francois0
Date of Patent
August 9, 2022
0
Patent Application Number
171263670
Date Filed
December 18, 2020
0
Patent Citations
‌
US Patent 10125171 Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof
‌
US Patent 10407466 Methods of selecting compstatin mimetics
‌
US Patent 10308687 Cell-penetrating compstatin analogs and uses thereof
‌
US Patent 11040107 Dosing regimens and related compositions and methods
‌
US Patent 11001610 Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof
‌
US Patent 10941184 Cell-penetrating compstatin analogs and uses thereof
‌
US Patent 10875893 Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods
‌
US Patent 10035822 Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods
Patent Citations Received
‌
US Patent 12059413 Methods of inhibiting viruses using compositions targeting TSG101-ubiquitin interaction
0
‌
US Patent 11661441 Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof
0
Patent Primary Examiner
‌
Julie Ha
0

In some aspects, the present invention cell-penetrating compstatin analog and compositions comprising cell-penetrating compstatin analog. In some aspects, the invention further provides methods of using cell-penetrating compstatin analogs treat a complement-mediated disorder, e.g., to inhibit complement-mediated damage to a cell, tissue, or organ, to inhibit production or release of biologically active C3 cleavage products.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11407789 Cell-penetrating compstatin analogs and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.